SNP | Gene | Chr | Risk/Other Allele | SNP Effect in European Whites | SNP Effect in African Americans | |||||
---|---|---|---|---|---|---|---|---|---|---|
Frequency of Risk Allele | OR | Ref | Frequency of Risk Allele in AA | Power to Detect OR of Magnitude Seen in Whites† | OR (95% CI)‡ | P Value from Metaanalysis | ||||
rs4730250* | 7q22 (DUS4L) | 7 | G / A | 0.17 | 1.17 | 9, 10 | 0.01 | 0.10 | NA | NA |
rs143383 | GDF5 | 20 | T / C | 0.59–0.68 | 1.16 | 11 | 0.12 | 0.46 | 0.92 (0.68–1.24) | 0.59 |
rs11842874 | MCF2L | 13 | A / G | 0.91–0.94 | 1.17 | 12 | 0.77 | 0.56 | 1.00 (0.80–1.26) | 0.98 |
rs6976 | GLT8D1 | 3 | T / C | 0.37 | 1.12 | 8 | 0.15 | 0.34 | 0.99 (0.75–1.30) | 0.95 |
rs11177 | GNL3 | 3 | A / G | 0.38 | 1.12 | 8 | 0.17 | 0.36 | 0.98 (0.75–1.27) | 0.87 |
rs4836732 | ASTN2 | 9 | C / T | 0.47 | 1.20 | 8 | 0.67 | 0.79 | 1.11 (0.90–1.35) | 0.33 |
rs9350591 | FILIP1; SENP6 | 6 | T / C | 0.11 | 1.18 | 8 | 0.12 | 0.54 | 0.90 (0.67–1.21) | 0.48 |
rs10492367* | KLHDC5; PTHLH | 12 | T / G | 0.19 | 1.14 | 8 | 0.01 | 0.09 | NA | NA |
rs835487 | CHST11 | 12 | G / A | 0.34 | 1.13 | 8 | 0.64 | 0.51 | 0.93 (0.77–1.15) | 0.53 |
rs12107036 | TP63 | 3 | G / A | 0.52 | 1.21 | 8 | 0.35 | 0.90 | 1.12 (0.91–1.38) | 0.29 |
rs8044769 | FTO | 16 | C / T | 0.50 | 1.11 | 8 | 0.76 | 0.32 | 0.94 (0.75–1.17) | 0.56 |
rs10948172 | SUPT3H; CDC5L | 6 | C / T | 0.29 | 1.14 | 8 | 0.30 | 0.59 | 0.95 (0.77–1.16) | 0.60 |
↵* SNP with a minor allele frequency < 0.05 were excluded from the metaanalysis.
↵† Power based on 742 cases and 475 controls, p = 0.05, and population prevalence of knee OA = 0.35.
↵‡ OR adjusted for age, sex, and population stratification. OA: osteoarthritis; SNP: single-nucleotide polymorphism; Chr: chromosome; Ref: reference; AA: African Americans; NA: not applicable.